Foothills Announces Drilling Results on its Labokay Well
Feb 14, 2017 12:02 pm UTC| Business
DENVER, Feb. 14, 2017 -- Foothills Exploration, Inc.(OTCQB:FTXP) (the “Company” or “Foothills”), an independent oil and gas exploration company engaged in the acquisition and development of oil and gas properties in the...
Foothills Announces Drilling Results on its Labokay Well
Feb 14, 2017 12:02 pm UTC| Business
DENVER, Feb. 14, 2017 -- Foothills Exploration, Inc.(OTCQB:FTXP) (the “Company” or “Foothills”), an independent oil and gas exploration company engaged in the acquisition and development of oil and gas properties in the...
21Vianet Group, Inc. to Announce Fourth Quarter and Full Year 2016 Financial Results
Feb 14, 2017 12:02 pm UTC| Business
BEIJING, Feb. 14, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its fourth...
21Vianet Group, Inc. to Announce Fourth Quarter and Full Year 2016 Financial Results
Feb 14, 2017 12:02 pm UTC| Business
BEIJING, Feb. 14, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its fourth...
21Vianet Group, Inc. to Announce Fourth Quarter and Full Year 2016 Financial Results
Feb 14, 2017 12:02 pm UTC| Business
BEIJING, Feb. 14, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its fourth...
Feb 14, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received Fast Track...
Feb 14, 2017 12:02 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, received Fast Track...